Hospital Research Partnership Targets Obesity

John Commins, for HealthLeaders Media , December 30, 2010

The partnership is the first corporate-sponsored research jointly undertaken by Sanford-Burnham and TRI. Advanced technologies, including genomic and metabolite profiling, will be used to identify metabolic signatures, genes and pathways that could serve as biomarkers, and novel drug targets aimed at developing more personalized treatments for obesity and its complications. The research model combines laboratory research with detailed investigations of patient cohorts so that scientists can compare data from experimental models and humans to identify genetic and metabolomic matches.

“This research partnership is a collaborative model that capitalizes on the synergistic expertise of each group and provides all partners with access to our Cardiometabolic Phenotyping, Metabolomics and Genomics technology cores,” says Daniel P. Kelly, MD, scientific director, Sanford-Burnham Medical Research Institute. “It offers much promise for expediting new drug candidates into Takeda’s development pipeline.”

The two-year collaboration includes research funding from Takeda divided between Florida Hospital-TRI and Sanford-Burnham. Takeda executives say the collaboration represents one of the largest discovery research partnerships that it has conducted with the not-for-profit sector.

“We view this collaboration as an opportunity to further Takeda’s goal of identifying targets for new therapeutics to treat obesity and its negative health consequences, including metabolic syndrome, diabetes, and heart disease.” says Paul Chapman, general manager, head of Pharmaceutical Research Division of Takeda.

The partners say the agreement will set the stage for future collaborative drug discovery campaigns aimed at novel therapeutics to treat obesity.

John Commins is a senior editor with HealthLeaders Media.

Comments are moderated. Please be patient.

1 comments on "Hospital Research Partnership Targets Obesity"

cheverblog (2/24/2011 at 5:59 AM)
We all know that obesity most specially in the US is a serious case of disease and health problems.Taht's why it is good to hear that theres a very good action for this.Combating Obesity will be very helpful to lessen the emerging diseases.Heart disease and cancer are just some example of this deathly illnesses that cause by the excessive fat in the body which mainly results to obesity.That's why New lap band surgery recommendations have been issued by the <a title="Food and Drug Administration relaxes eligibility requirements for lap band surgery"href=""> FDA</a>..And this Community Health Status Indicators (CHSI)will also be a great help for those hopeful ones.




FREE e-Newsletters Join the Council Subscribe to HL magazine


100 Winners Circle Suite 300
Brentwood, TN 37027


About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2015 a division of BLR All rights reserved.